Even so, this sell off does seem a bit overdone. It was down nearly 25% yesterday from the close prior to the update. Two large trades of around a million shares each snuck in at 537.5p before the close yesterday so I guess someone is seeing this downturn as a buying opportunity?
Sorry to hear that. I really do think analysts/brokers do talk hog wash. How can they come up with a comment like "Unfortunately, a large number of physicians aren't regularly reordering Varithena after completing initial patient valuations." without giving any explanation as to why physicians are not reordering. For all I know its because Varithena isnt working!! In fact the company leaving the explanation to investors imagination is hardly clever. I am only in for a few K but wont be tempted until the board start understanding why investors like me are so nervous.
At this rate maybe the BOD's incentive scheme needs an overhaul. we have not much out of this company other than the old Grace Brothers type of communication You are all doing very well etc. I see Invest have been lightening up maybe they too are beginning to wonder who the company is being run for.
Hopefully a good grab for you slipperyslope. My issue is this company trades at a PE of over 60 so major increases in T/O and profit are already priced in and some of their excuses smack a little bit of inexperience of how long its takes to get these products earning a decent revenue stream. Purely anecdontal opinion on my part.
The revenue for this company is up year on year over last 5 years and this year again is going to be better than the last. Looks good to me. As Jefferies point out sp had already taken this all in to account over last 6 months. I grabbed some of these on the 15% drop and happy to hold now.
Price currently down over 10% from yesterday's close after the close period update announced that revenues would be in the lower half of guidance range. Jefferies expects price to fall 5% but keeps "buy" recommendation on basis that share price is already discounted.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.